Bruker (BRKR) Asset Writedowns and Impairment (2010 - 2024)

Bruker has reported Asset Writedowns and Impairment for 12 years, with the latest figure at $32.7 million in Q4 2024.

• For the quarter ending Q4 2024, Asset Writedowns and Impairment rose 32800.0% year-over-year to $32.7 million; the trailing twelve-month figure through Dec 2024 stood at $54.3 million (up 198.35% YoY), and the FY2025 full-year result was $76.0 million, up 26.25% from the prior year.
• Asset Writedowns and Impairment for Q4 2024 stood at $32.7 million, up from $20.2 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $32.7 million in Q4 2024, with the low at -$1.9 million in Q3 2022.
• Historically, Asset Writedowns and Impairment has averaged $7.4 million across 3 years, with a median of $1.8 million in 2022.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 106.25% — and 2024, when it soared 32800.0%.
• Bruker's Asset Writedowns and Impairment stood at $1.6 million in 2022, then slumped by 106.25% to -$100000.0 in 2023, then soared by 32800.0% to $32.7 million in 2024.
• The last three Asset Writedowns and Impairment figures came in at $32.7 million (Q4 2024), $20.2 million (Q2 2024), and $1.4 million (Q1 2024), per Business Quant data.